Clinical Trial Update: Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of mirabegron in Taiwanese patients with overactive bladder and urinary incontinence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Urinary Incontinence, Overactive Bladder Syndrome | Phase 3 | Status: COMPLETED